| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |